Future perspectives of cell-based therapy for intervertebral disc disease

Area of Science:

• Regenerative Medicine
• Orthopedics
• Biomedical Engineering

Background:

• Intervertebral disc degeneration is a major cause of low back pain, incurring significant societal costs.
• Cell-based therapies offer a potential biological treatment for disc disease, aiming to preserve spinal motion.
• Current research shows promise in animal models, but clinical translation requires further investigation.

Purpose of the Study:

• To review current concepts in cell-based therapy for intervertebral disc disease.
• To update on potential cell sources investigated in animal models.
• To discuss challenges and future perspectives for clinical application.

Main Methods:

• Review of current literature on cell-based therapies for intervertebral disc disease.
• Analysis of findings from animal models.
• Discussion of hurdles to clinical translation.

Main Results:

• Emerging research in cell-based therapies for disc disease shows promising results in animal models.
• A deeper understanding of disc cell phenotype, differentiation, and microenvironment is crucial.
• Significant hurdles remain for the clinical application of these therapies.

Conclusions:

• Cell-based therapies represent a developing field for treating intervertebral disc disease.
• Optimization of efficacy, methodology, and safety is essential for future clinical success.
• Continued research into cell biology and microenvironment is key to advancing treatment options.